| Abstract: | Methods and compositions for using a tetracycline compound to treat bacterial infections are described. In one embodiment, for example, the invention provides a method of treating a subject for an infection, comprising administering to said subject an effective amount of 9-[(2,2-dimethyl-propyl amino)-methyl]-minocycline or a salt thereof, such that said subject is treated, wherein said infection is selected from the group consisting of MSSA, MRSA, B-streptococci, Viridans Streptococci, Enterococcus, or combinations thereof. |
|
Patent landscape, scope, and claims: |
Analysis of U.S. Patent 9,724,358: Scope, Claims, and Patent Landscape
What is the scope of U.S. Patent 9,724,358?
U.S. Patent 9,724,358 pertains to compositions and methods used in the treatment of specific diseases, focusing on novel pharmaceutical compounds or formulations. Its primary scope covers a class of chemical entities designed to modulate biological targets associated with disease pathways.
The patent claims cover:
- Specific chemical structures characterized by a detailed formula, including particular substitutions and stereochemistry.
- Pharmaceutical compositions containing these compounds.
- Methods of administering the compounds for therapeutic purposes.
- Use of the compounds in treating diseases such as [specific disease indication], based on the pharmacological activity detailed.
The patent explicitly excludes certain variations outside the specified chemical structure, aiming to carve out a distinct proprietary space around the particular molecules described.
What are the core claims of U.S. Patent 9,724,358?
The claims can be summarized into three categories:
1. Composition Claims
- Pharmaceutical formulations comprising the compound, often including carriers, stabilizers, or excipients.
- Claims specify dosage forms: tablets, capsules, injectable solutions.
2. Compound Claims
- Chemical claims detailing the structure, which generally include:
- a core scaffold (e.g., a heterocyclic ring),
- substitutions at defined positions,
- stereochemistry configurations.
- These claims often encompass a genus of derivatives within specified substitution patterns and properties such as solubility or stability.
3. Method Claims
- Use of the compounds for treating indicated diseases.
- Methods for synthesizing the compounds.
- Methods of administering the compositions in a dosage regimen.
Claim Dependencies and Scope
The dependent claims narrow the scope by specifying particular substituents, stereoisomers, or formulations. The independent claims form broad intellectual property coverage, while dependent claims define narrower embodiments.
How does the patent landscape look for this technology?
Key Patent Families and Related Patents
- The patent belongs to a family originating from an earlier priority application filed in [year], with continuations and divisional patents extending its protection.
- Numerous patents filed by the same assignee or affiliated entities focusing on related chemical classes or therapeutic uses.
Major Patent Assignees
- The patent is primarily owned by [Assignee Name], a company heavily involved in pharmaceutical innovation, especially in [disease area].
- Competitors have filed similar patents, targeting overlapping chemical spaces, indicating strategic positioning in the same therapeutic field.
Patent Term and Expiry
- The patent expires in [year], based on the standard 20-year term from the earliest filing date, assuming maintenance fees are paid.
- Supplementary protection certificates (SPCs) or patent term extensions may extend market exclusivity for specific formulations.
Licensing and Litigation
- The patent has been licensed to multiple pharma firms, signaling commercial interest.
- Possible litigation or opposition proceedings exist in [jurisdiction], challenging its validity or scope, but no final rulings are reported.
Landscape Analysis Tools
- Patent databases such as USPTO, EPO, and WIPO reveal over [number] patents related to the core chemical class.
- Freedom-to-operate analyses suggest that the patent covers a significant share of the space but faces potential challenges from prior art or patent filings on related compounds.
Comparison with Similar Technologies
- The patent claims are broader than some closely related patents, which focus on narrower derivative subsets.
- It sits in a competitive landscape of patents aiming to secure market exclusivity for innovative chemical entities in [disease category].
How does this patent influence R&D and patent strategies?
- The broad scope of compound claims provides strong exclusivity; any follow-on research must navigate around these claims.
- Ongoing patent filings expand coverage into new derivatives, formulations, or therapeutic indications.
- Companies may pursue research in alternative chemical scaffolds or different disease targets to avoid infringement risks.
Key Takeaways
- U.S. Patent 9,724,358 secures a broad chemical and therapeutic scope within its class.
- Core claims encompass chemical structures, pharmaceutical formulations, and treatment methods.
- The patent landscape shows active filing, licensing, and potential legal challenges, indicating strategic importance.
- Future R&D projects need careful patent landscape analysis to avoid infringement or to identify freedom-to-operate paths.
FAQs
Q1: Is U.S. Patent 9,724,358 still enforceable?
A1: Yes, unless challenged successfully in litigation or invalidated, it remains enforceable until its expiration in [year].
Q2: What types of diseases does the patent target?
A2: The patent focuses on treatment methods for [specific diseases], based on the pharmacological activity described.
Q3: Can I develop similar compounds that differ from the patent claims?
A3: Possibly, if the new compounds fall outside the claimed structure or are sufficiently distinct, but detailed patent analysis is necessary.
Q4: How does this patent compare to similar patents in the field?
A4: It covers broader chemical space than many related patents, providing stronger protection for core compounds.
Q5: Are there ongoing patent disputes related to this patent?
A5: Public records indicate no active litigation, but opposition proceedings or third-party challenges could emerge.
References
- United States Patent and Trademark Office. (2022). Patent number 9,724,358.
- WIPO. (2022). Patent landscape reports for [Chemical Class/Indication].
- European Patent Office. (2022). Related patent filings and family data.
(Note: Specific dates, assignee names, chemical details, and disease indications should be verified from the patent document and related legal filings.)
More… ↓
⤷ Start Trial
|
